Background Understanding the ‘real-world’ challenges of delivery of pre-exposure prophylaxis (PrEP) among men who have sex ...

The most useful thing about a new HIV-prevention guide may be a question it never asks: Why do you want to know about ...

In a far-reaching effort to understand the factors contributing to HIV transmission among sexual and gender minority (SGM) individuals and improve HIV prevention strategies, a team of scientists at ...

Lenacapavir (LEN) has arrived in South Africa, and this injectable form of pre-exposure prophylaxis (PrEP) marks a major ...

HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...

Tristan Schukraft on building MISTR, preserving queer spaces, expanding Tryst Hotels and why six boyfriends made financial ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

Pre-exposure prophylaxis (PrEP) has emerged as a transformative biomedical intervention capable of reducing HIV transmission risk by up to 99% when adherence is optimal. Initially piloted in ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...

Pre-exposure prophylaxis (PrEP) has revolutionised HIV prevention by offering antiretroviral medication to HIV-negative individuals at substantial risk of infection. Widespread adoption has delivered ...

The number of people taking a vital anti-HIV drug has fallen by almost two-fifths in just one year in the aftermath of ...

A total of 15,000 doses of injectable Lenacapavir (LEN) for use as a pre-exposure prophylaxis (PrEP) against HIV are expected ...